2,3′,4,4′,5′-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice

British Journal of Pharmacology

Volumn 160, Issue 6, 2010, Pages 1352-1361

  Li, Haitao ^a   Wu, William Ka Kei ^b   Li, Zhi Jie ^b   Chan, Kam Ming ^b   Wong, Clover Ching Man ^b   Ye, Cai Guo ^b   Yu, Le ^b   Sung, Joseph Jao Yiu ^b   Cho, Chi Hin ^b   Wang, Mingfu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

chemoprevention; colitis; colon carcinogenesis; resveratrol derivatives

Indexed keywords

2,3',4,4',5' PENTAMETHOXYSTILBENE; AZOXYMETHANE; BETA CATENIN; DEXTRAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RESVERATROL; SODIUM DIHYDROGEN PHOSPHATE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; 2,3',4,4',5'-PENTAMETHOXYSTILBENE; DEXTRAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL STRAIN HT29; CHEMOPROPHYLAXIS; COLITIS; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; COLON TUMOR; COLORECTAL TUMOR; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; MALE; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; AZOXYMETHANE; CELL LINE, TUMOR; CELL PROLIFERATION; COLITIS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED BALB C; STILBENES;

EID: 77954036696     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00785.x     Document Type: Article

References (30)

1. Baur JA, Sinclair DA (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5 : 493 506.
2. Bertagnolli MM, Hamilton SR (2005). Chemoprevention of colorectal cancer. In : Kelloff GJ, Hawk ET, Sigman CC (eds). Cancer Chemoprevention: Strategies for Cancer Chemoprevention. Humana Press
3. Clapper ML, Cooper HS, Chang WC (2007). Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 28 : 1450 1459.
4. Clapper ML, Gary MA, Coudry RA, Litwin S, Chang WCL, Devarajan K et al. (2008). 5-Aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis. Inflamm Bowel Dis 14 : 1341 1347.
5. Feagins LA, Souza RF, Spechler SJ (2009). Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nature 6 : 297 305.
6. Gosslau A, Chen M, Ho CT, Chen KY (2005). A methoxy derivative of resveratrol analogue selectively induced activation of mitochondrial apoptotic pathway in transformed fibroblasts. Br J Cancer 92 : 513 521.
7. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell 100 : 57 70.
8. Haridas V, Hanausek M, Nishimura G, Soehnge H, Gaikwad A, Narog M et al. (2004). Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J Clin Invest 113 : 65 73.
9. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 : 218 220.
10. Jänne PA, Mayer RJ (2000). Chemoprevention of colorectal cancer. N Engl J Med 342 : 1960 1968.
11. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008). Cancer statistics. CA Cancer J Clin 58 : 71 96.
12. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA et al. (2008). Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 68 : 3985 3991.
13. Kim S, Ko H, Park JE, Jung S, Lee SK, Chun YJ (2002). Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J Med Chem 45 : 160 164.
14. Li H, Wu WK, Zheng Z, Che CT, Yu L, Li ZJ et al. (2009). 2,3′,4,4′,5′-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules. Biochem Pharmacol 78 : 1224 1232.
15. Ma Z, Molavi O, Haddadi A, Lai R, Gossage RA, Lavasanifar A (2008). Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol. Cancer Chemother Pharmacol 63 : 27 35.
16. McKenzie SJ, Baker MS, Buffinton GD, Doe WF (1996). Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 98 : 136 141.
17. Martín AR, Villegas I, Sánchez-Hidalgo M, de la Lastra CA (2006). The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol 147 : 873 885.
18. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P et al. (2004). Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12 : 5571 5578.
19. Murias M, Jager W, Handler N, Erker T, Horvath Z, Szekeres T et al. (2005). Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem Pharmacol 69 : 903 912.
20. Park H, Aiyar SE, Fan P, Wang J, Yue W, Okouneva T et al. (2007). Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action. Cancer Res 67 : 5717 5726.
21. Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J et al. (2006). Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355 : 1863 1872.
22. Robeti M, Pizziranti D, Simoni D, Rondanin R, Baruchello R, Bonora C et al. (2003). Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J Med Chem 46 : 3546 3554.
23. Sale S, Verschoyle RD, Boocock D, Jones DJL, Wilsher N, Rupareliak C et al. (2004). Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Br J Cancer 90 : 736 744.
24. Min+ mouse and cyclooxygenase-2 in human-derived colon cancer cells. Int J Cancer 115 : 194 201.
25. Seril DN, Liao J, Yang GY, Yang CS (2003). Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24 : 353 362.
26. Simoni D, Romagnoli R, Baruchello R, Rondanin R, Rizzi M, Pavani MG et al. (2006). Novel combretastatin analogues endowed with antitumor activity. J Med Chem 49 : 3143 3152.
27. Sinicrope FA, Gill S (2004). Role of cyclooxygenase-2 in colorectal cancer. Cancer Metast Rev 23 : 63 75.
28. Suh N, Paul S, Hao X, Simi B, Xiao H, Rimando AM et al. (2007). Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats. Clin Cancer Res 13 : 350 355.
29. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H (2003). A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94 : 965 973.
30. Wang M, Jin Y, Ho CT (1999). Evaluation of resveratrol derivatives as potential antioxidants and identification of a reaction product of resveratrol and 2,2-dipphenyl-1-picryhydrazyl radical. J Agric Food Chem 47 : 3974 3977.